Boundless Bio Inc. Financial Overview
Boundless Bio Inc.'s market cap is currently $27.09M. The company's EPS TTM is $-0.62; its P/E ratio is -0.44; Boundless Bio Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
